Browsing Modes for Business Users

Bevacizumab antibody | AbD16748_hIgG1

Human anti Bevacizumab

Product Type
Monoclonal Antibody
Clone
AbD16748_hIgG1
Isotype
IgG1
Specificity
Bevacizumab

Product Code Applications Pack Size List Price Your Price Qty
HCA184G
Datasheet Datasheet Datasheet
SDS Safety Datasheet SDS
E 1 mg loader
List Price Your Price
loader
HCA184
Datasheet Datasheet Datasheet
SDS Safety Datasheet SDS
E 0.1 mg loader
List Price Your Price
loader

Human Anti-Bevacizumab Antibody, clone AbD16748_IgG1 is a paratope-specific, recombinant anti-idiotypic antibody that specifically recognizes the humanized monoclonal antibody drug bevacizumab and inhibits the binding of the drug to its target, vascular endothelial growth factor A (VEGF-A). The antibody can be used to measure the levels of bevacizumab and biosimilars in serum from patients.

A pair of anti-bevacizumab antibodies can be used to develop a pharmacokinetic (PK) bridging ELISA to measure free drug. This antibody is recommended as the detection antibody, paired with Anti-Bevacizumab Antibody in monovalent Fab format, clone AbD17976 (HCA182) as the capture antibody.

Bevacizumab (reference product branded as Avastin) is a humanized monoclonal antibody (IgG1/kappa) that inhibits angiogenesis by binding to VEGF-A. VEGF-A is a potent stimulator of angiogenesis of both normal and cancerous cells, and acts as a regulator of vasculogenesis. Bevacizumab is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.

View a summary of all Anti-Bevacizumab Antibodies.

Product Form
Human IgG1 antibody (kappa light chain) selected from the HuCAL phage display library and expressed in a human cell line. This antibody is supplied as a liquid.
Preparation
HCA184G: Purified IgG prepared by affinity chromatography on Protein A
HCA184: Purified IgG prepared by affinity chromatography on Protein A.
Source
HKB-11
Buffer Solution
HCA184G: Phosphate buffered saline
HCA184: Phosphate buffered saline.
Preservative Stabilisers
0.09% Sodium Azide (NaN3)
Immunogen
Bevacizumab
Purity
HCA184G: 97.8% (capillary electrophoresis, reducing conditions)
HCA184: 97.8% (capillary electrophoresis, reducing conditions).
Affinity
HCA184G: The intrinsic affinity of the monovalent form of this antibody is KD=2.1nM as measured by real time, label-free molecular interaction analysis on immobilized Bevacizumab.
HCA184: The monovalent intrinsic affinity of this antibody is KD=2.1nM as measured by real time, label-free molecular interaction analysis on immobilized Bevacizumab.
Approx. Protein Concentrations
HCA184G: Antibody concentration 1.0 mg/ml
HCA184: Antibody concentration 0.5 mg/ml.
Regulatory
HCA184G: For research purposes only
HCA184: For research purposes only.
Guarantee
HCA184G: 12 months from date of despatch
HCA184: 12 months from date of despatch.
Acknowledgements
This product and/or its use is covered by claims of U.S. patents, and/or pending U.S. and non-U.S. patent applications owned by or under license to Bio-Rad Laboratories, Inc. See bio-rad.com/en-us/trademarks for details.
Avastin is a trademark of Genentech, Inc.

This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
ELISA
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Technical Advice
Recommended protocols and further information about HuCAL recombinant antibody technology can be found in the HuCAL Antibodies Technical Manual.
ELISA
This product may be used in a direct ELISA or as a detection reagent in a sandwich ELISA, when conjugated to HRP, together with HCA182 as the capture reagent.
Protocol: PK bridging ELISA to measure free drug
This antibody is fully human and can be used as a reference standard in an ADA assay.
Protocol: ADA bridging ELISA.

Description Product Code Applications Pack Size List Price Your Price Quantity
Human anti Bevacizumab HCA182 E 0.1 mg loader
List Price Your Price
loader
Description Human anti Bevacizumab
Human anti Bevacizumab HCA185 E 0.1 mg loader
List Price Your Price
loader
Description Human anti Bevacizumab
LYNX Rapid HRP Antibody Conjugation Kit LNK001P CJ 1 Conjugation For 400µg Antibody
List Price Your Price
Description LYNX Rapid HRP Antibody Conjugation Kit

References for Bevacizumab antibody

  1. Kashiwagi, N. et al. (2017) Method for measuring anti-drug antibody
    US Patent Application US20170315118A1
  2. Lallemand, C. et al. (2020) Quantification of Bevacizumab Activity Following Treatment of Patients With Ovarian Cancer or Glioblastoma.
    Front Immunol. 11: 515556.

Synonyms
Avastin
Licensed Use
For in vitro. research purposes and for commercial applications for the provision of in vitro. testing services to support preclinical and clinical drug development. Any re-sale in any form or any other commercial application needs a written agreement with Bio-Rad.

HCA184G

148601 1709

HCA184

155646 1609

If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.

View more products with BEVACIZUMAB specificity

Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"

Please note